Israeli Gut Microbiome Analysis Startup DayTwo Raises $31 Million
DayTwo offers personalized nutrition optimization suggestions based on feces analysis, designed to reduce risk of diabetes and other metabolic diseases
Hagar Ravet | 13:00 26.06.2019
Israeli gut microbiome analysis startup DayTwo Ltd. announced Wednesday it has completed a $31 million investment round. The series B round was led by Israel-based life sciences, healthcare, and technology venture capital firm aMoon, and Israeli venture capitalist Yahal Zilka's new fund, Ofek Ventures. Existing investors Johnson & Johnson, Seventure Partners, and Israeli basketball player Omri Casspi also participated. This round brings DayTwo's total funds raised to date to $48 million.